Work

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists

Year: 2025

Type: article

Abstract: OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To compare the blood pressure effects of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists with the blood pressure effects of glucagon-like peptide-1 (GLP-1) receptor agonists.

Source: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858.cd016144

Authors: Guillaume Grenet, Arthur Gougeon, Douglas M Salzwedel, Ciprian D Jauca, James M Wright

Institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, University of British Columbia, Hospices Civils de Lyon, Laboratoire de Biométrie et Biologie Evolutive

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4409507517

FWCI: 0.591

Cites: 43

Cited by: 1

Related to: 10